Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection (Q46447283)

22 December 2017

title

Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection (English)

1 reference

22 December 2017

1 reference

1 reference

Man-Fung Yuen

1

1 reference

22 December 2017

Danny Ka-Ho Wong

2

1 reference

22 December 2017

Simon Siu-Man Sum

3

1 reference

22 December 2017

He-Jun Yuan

4

1 reference

22 December 2017

John Chi-Hang Yuen

5

1 reference

22 December 2017

Annie On-On Chan

6

1 reference

22 December 2017

Benjamin Chun-Yu Wong

7

1 reference

22 December 2017

Ching-Lung Lai

8

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

The American Journal of Gastroenterology

published in

1 reference

22 December 2017

volume

100

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

1099-1103

1 reference

22 December 2017

Hepatitis B virus biology

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Experimental transmission of duck hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Human hepatocytes transplanted into genetically immunocompetent rats are susceptible to infection by hepatitis B virus in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Configuration and replication competence of hepatitis B virus DNA in peripheral blood mononuclear cells from chronic hepatitis B patients and patients who have recovered from acute self-limited hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41530.X

10.1111/J.1572-0241.2005.41530.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15842584

1 reference

22 December 2017